Literature DB >> 29467899

TNF-α promotes colon cancer cell migration and invasion by upregulating TROP-2.

Peng Zhao1, Zhongtao Zhang1.   

Abstract

High levels of tumor-associated calcium signal transduction protein (TROP)-2 have been demonstrated to be strongly associated with tumor necrosis factor (TNF)-α levels in colon cancer. In the present study, the effect of TNF-α on the regulation of TROP-2 expression and its effect in colon cancer cell migration and invasion were investigated in vitro. TROP-2 protein levels were evaluated in HCT-116 human colon cancer cells cultured with various concentrations of TNF-α using western blot analysis. Changes in the migratory and invasive potential of the cells were evaluated using a wound healing and transwell assay, respectively. Then, TROP-2 expression was downregulated in cells by use of siRNA, and TROP-2 knockdown was confirmed at the mRNA and protein level by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The migration and invasion potential of cells transfected with TROP-2 siRNA was also evaluated. Levels of several mitogen-activated protein kinase proteins, namely p38, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK), were detected in cells treated with TNF-α using western blot analysis. The results demonstrated that TROP-2 protein levels increased in cells treated with lower concentrations of TNF-α, but decreased in cells treated with higher concentrations of TNF-α, compared with untreated control. Maximum TROP-2 levels were observed in cells treated with 20 µg/l TNF-α. Migration and invasion were enhanced in cells treated with 20 µg/l TNF-α. When TROP-2 was silenced in colon cancer cells by siRNA, migration and invasion were significantly decreased compared with control cells. TNF-α stimulation activated the ERK1/2 pathway, but did not significantly affect p38 and JNK phosphorylation levels. Treatment with a specific ERK1/2 inhibitor suppressed the TNF-α-induced upregulation of TROP-2 and the TNF-α-induced colon cancer cell migration and invasion. In conclusion, the present results demonstrated that low concentrations of TNF-α significantly enhanced colon cancer cell migration and invasion by upregulating TROP-2 via the ERK1/2 signaling pathway.

Entities:  

Keywords:  colon cancer; metastasis; tumor invasion; tumor necrosis factor-α; tumor-associated calcium signal transduction protein-2

Year:  2018        PMID: 29467899      PMCID: PMC5796310          DOI: 10.3892/ol.2018.7735

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

3.  Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.

Authors:  Lara P Stepan; Esther S Trueblood; Kari Hale; John Babcook; Luis Borges; Claire L Sutherland
Journal:  J Histochem Cytochem       Date:  2011-05-06       Impact factor: 2.479

4.  Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.

Authors:  Neelakandan Muthukumaran; Karl E Miletti-González; Abhilash K Ravindranath; Lorna Rodríguez-Rodríguez
Journal:  Mol Cancer Res       Date:  2006-08       Impact factor: 5.852

5.  Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy.

Authors:  Arianna Calcinotto; Matteo Grioni; Elena Jachetti; Flavio Curnis; Anna Mondino; Giorgio Parmiani; Angelo Corti; Matteo Bellone
Journal:  J Immunol       Date:  2012-02-08       Impact factor: 5.422

6.  Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.

Authors:  Eliana Bignotti; Paola Todeschini; Stefano Calza; Marcella Falchetti; Maria Ravanini; Renata A Tassi; Antonella Ravaggi; Elisabetta Bandiera; Chiara Romani; Laura Zanotti; Germana Tognon; Franco E Odicino; Fabio Facchetti; Sergio Pecorelli; Alessandro D Santin
Journal:  Eur J Cancer       Date:  2010-01-08       Impact factor: 9.162

7.  TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.

Authors:  Dominic Fong; Gilbert Spizzo; Johanna M Gostner; Guenther Gastl; Patrizia Moser; Clemens Krammel; Stefan Gerhard; Michael Rasse; Klaus Laimer
Journal:  Mod Pathol       Date:  2007-12-14       Impact factor: 7.842

8.  Significance of EpCAM and TROP2 expression in non-small cell lung cancer.

Authors:  Min Gyoung Pak; Dong Hoon Shin; Chang Hun Lee; Min Ki Lee
Journal:  World J Surg Oncol       Date:  2012-04-06       Impact factor: 2.754

9.  High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

Authors:  D Fong; P Moser; C Krammel; J M Gostner; R Margreiter; M Mitterer; G Gastl; G Spizzo
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

10.  BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma.

Authors:  Yong Wang; Qinhao Guo; Yan Zhao; Jiejing Chen; Shuwei Wang; Jun Hu; Yueming Sun
Journal:  Oncol Lett       Date:  2014-08-28       Impact factor: 2.967

View more
  31 in total

1.  Anticancer Effect of Ruscogenin in B(a)P-Induced Lung Cancer in Mice via Modulation of Proinflammatory Cytokines and Mitochondrial Enzymes.

Authors:  Jun Zhao; Bangzhi He; Vidya Devanathadesikan Seshadri; Shaohua Xu
Journal:  Appl Biochem Biotechnol       Date:  2022-07-14       Impact factor: 3.094

2.  Tumor necrosis factor alpha delivers exogenous inflammation-related microRNAs to recipient cells with functional targeting capabilities.

Authors:  Yuechao Zhao; Tan Zhang; Xuelian Shen; Aixue Huang; Hui Li; Lin Wang; Xuemei Liu; Xuejun Wang; Xiang Song; Shengqi Wang; Jie Dong; Ningsheng Shao
Journal:  Mol Ther       Date:  2022-07-05       Impact factor: 12.910

3.  Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.

Authors:  Shota Omori; Koji Muramatsu; Takuya Kawata; Eriko Miyawaki; Taichi Miyawaki; Nobuaki Mamesaya; Takahisa Kawamura; Haruki Kobayashi; Kazuhisa Nakashima; Kazushige Wakuda; Akira Ono; Hirotsugu Kenmotsu; Tateaki Naito; Haruyasu Murakami; Takashi Sugino; Toshiaki Takahashi
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-17       Impact factor: 4.322

Review 4.  The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target.

Authors:  David M Goldenberg; Rhona Stein; Robert M Sharkey
Journal:  Oncotarget       Date:  2018-06-22

5.  Down-regulation of CXCL11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition.

Authors:  Yu Jie Gao; De Lin Liu; Sheng Li; Gao Feng Yuan; Li Li; Hong Yan Zhu; Guan Yi Cao
Journal:  Onco Targets Ther       Date:  2018-10-23       Impact factor: 4.147

6.  pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks.

Authors:  Ege Ulgen; Ozan Ozisik; Osman Ugur Sezerman
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

7.  Pretreatment of Anthocyanin from the Fruit of Vitis coignetiae Pulliat Acts as a Potent Inhibitor of TNF-α Effect by Inhibiting NF-κB-Regulated Genes in Human Breast Cancer Cells.

Authors:  Anjugam Paramanantham; Min Jeong Kim; Eun Joo Jung; Arulkumar Nagappan; Jeong Won Yun; Hye Jung Kim; Sung Chul Shin; Gon Sup Kim; Won Sup Lee
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

Review 8.  Cohesive cancer invasion of the biophysical barrier of smooth muscle.

Authors:  William L Harryman; Kendra D Marr; Daniel Hernandez-Cortes; Raymond B Nagle; Joe G N Garcia; Anne E Cress
Journal:  Cancer Metastasis Rev       Date:  2021-01-04       Impact factor: 9.264

9.  Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE).

Authors:  Chenyun Wu; Xinyue Du; Lili Tang; Jianhua Wu; Wei Zhao; Xiaokui Guo; Dengyu Liu; Wei Hu; Helena Helmby; Guangjie Chen; Zhaojun Wang
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

10.  Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.

Authors:  Baoping Zhang; Shuting Gao; Ruiping Li; Yiting Li; Rui Cao; Jingyang Cheng; Yumeng Guo; Errui Wang; Ying Huang; Kailiang Zhang
Journal:  BMC Cancer       Date:  2020-08-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.